Lv1
2 积分 2026-09-07 加入
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents
11小时前
已完结
Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants
11小时前
已完结
In vivo Pharmacokinetic/Pharmacodynamic Analysis of the Efficacy of the Cefepime/Nacubactam Combination Against β-Lactamase-Producing Enterobacterales based on the Instantaneous MIC Concept
11小时前
已完结
In vivo Pharmacokinetic/Pharmacodynamic Analysis of the Efficacy of the Cefepime/Nacubactam Combination Against β-Lactamase-Producing Enterobacterales based on the Instantaneous MIC Concept
11小时前
已完结
Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial
11小时前
已完结
2025 guideline updates for community-acquired pneumonia diagnosis and management
1个月前
已完结
Benign prostatic hyperplasia genetic variants in Asians
1个月前
已完结
Hiperplasia benigna de próstata
1个月前
已完结
Benign prostatic hyperplasia
1个月前
已完结
皖公网安备34019202002308
